An open-label, first-in-human, single agent, dose escalation study for the evaluation of safety and efficacy of SAR442085 in patients with relapsed or refractory multiple myeloma
- Kapoor, P.
- Nathwani, N.
- Jelinek, T.
- Pour, L.
- Perrot, A.
- Dimopoulos, M.-A.
- Huang, S.-Y.
- Spicka, I.
- Chhabra, S.
- Lichtman, E.
- Mateos, M.-V.
- Kanagavel, D.
- Zhao, L.
- Guillemin-Paveau, H.
- Macé, S.
- van de Velde, H.
- Richardson, P.G.
Revista:
European Journal of Haematology
ISSN: 1600-0609, 0902-4441
Ano de publicación: 2024
Tipo: Artigo